QI
INSY

QS Investors’s Insys Therapeutics, Inc. INSY Stock Holding History

QS Investors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-155,683
Closed -$719K – 1711
2019
Q1 		$719K Sell
155,683
-3,450
-2% -$16.3K 0.01% 899
2018
Q4 		$557K Hold
159,133
– – 0.01% 890
2018
Q3 		$1.6M Hold
159,133
– – 0.02% 684
2018
Q2 		$1.15M Buy
159,133
+26
+0% +$181 0.01% 749
2018
Q1 		$961K Sell
159,107
-11,964
-7% -$98.8K 0.01% 791
2017
Q4 		$1.65M Sell
171,071
-9,238
-5% -$60.5K 0.02% 653
2017
Q3 		$1.6M Hold
180,309
– – 0.01% 681
2017
Q2 		$2.28M Sell
180,309
-1,826
-1% -$21.6K 0.02% 553
2017
Q1 		$1.91M Hold
182,135
– – 0.02% 625
2016
Q4 		$1.68M Hold
182,135
– – 0.01% 655
2016
Q3 		$2.15M Hold
182,135
– – 0.02% 632
2016
Q2 		$2.36M Hold
182,135
– – 0.02% 607
2016
Q1 		$2.91M Hold
182,135
– – 0.03% 549
2015
Q4 		$5.21M Sell
182,135
-3,901
-2% -$108K 0.05% 377
2015
Q3 		$5.29M Sell
186,036
-2,200
-1% -$81K 0.06% 338
2015
Q2 		$6.76M Hold
188,236
– – 0.08% 290
2015
Q1 		$5.47M Hold
188,236
– – 0.06% 346
2014
Q4 		$3.97M Buy
+188,236
New +$3.72M 0.05% 420

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

QS Investors's INSY Position: Q2 2019 in Review

QS Investors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 155,683 shares — an estimated $719K sold.

QS Investors first reported a position in INSY in Q4 2014 and held it in 18 quarters. The position peaked at $6.76M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • QS Investors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • QS Investors sold 155,683 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $719K.
  • QS Investors first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 18 quarters.
  • QS Investors's Insys Therapeutics, Inc. position peaked at $6.76M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on QS Investors's 13F filing for Q2 2019, filed 14 Aug 2019.